Skip to menu Skip to content Skip to footer
Associate Professor Helmut Schaider
Associate Professor

Helmut Schaider

Email: 
Phone: 
+61 7 344 38027

Overview

Availability

Associate Professor Helmut Schaider is:
Available for supervision

Qualifications

  • Bachelor of Medicine, Karl-Franzens- Universität Graz
  • Certificate of Dermatology, Australasian College of Dermatologists

Works

Search Professor Helmut Schaider’s works on UQ eSpace

181 works between 1991 and 2024

21 - 40 of 181 works

2022

Journal Article

In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case series

Sanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H. Peter and Schaider, Helmut (2022). In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case series. Cancers, 14 (11) 2801, 2801. doi: 10.3390/cancers14112801

In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case series

2022

Journal Article

Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial

Chong, Sharene, Wong, Ho Yi, Althabteh, Ahmad, Cox, Charlotte, Stevenson, Paul H., Brown, Susan, Griffin, Anthony, Isbel, Nicole, Siller, Gregory, Soyer, H. Peter, Schaider, Helmut, Roy, Edwige, Campbell, Scott, Green, Adele C. and Khosrotehrani, Kiarash (2022). Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial. Journal of the American Academy of Dermatology, 87 (5), 1163-1166. doi: 10.1016/j.jaad.2022.02.039

Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial

2022

Journal Article

Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort study

Horsham, Caitlin, O'Hara, Montana, Sanjida, Saira, Ma, Samantha, Jayasinghe, Dilki, Green, Adele C, Schaider, Helmut, Aitken, Joanne F, Sturm, Richard A, Prow, Tarl, Soyer, H. Peter and Janda, Monika (2022). Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort study. JMIR Dermatology, 5 (2) e37034, e37034. doi: 10.2196/37034

Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort study

2021

Conference Publication

Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer

Su, C., Bond, C., Fennell, L., Kerr, G., Jarde, T., Micati, D., Engel, R., Chan, W. H., Hlavca, S., Archer, S., Mcmurrick, P., Hammerlindl, H., Lim, F., Salik, B., Mckeone, D., Hartel, G., Leggett, B., Schaider, H., Abud, H., Boyle, G., Burge, M. and Whitehall, V. (2021). Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer. GESA AGW 2021, Online, 4 - 12 September 2021. HOBOKEN: WILEY.

Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer

2021

Journal Article

An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomas

Wang, Jing, Kao, Yung‐Ching, Zhou, Quan, Wuethrich, Alain, Stark, Mitchell S., Schaider, Helmut, Soyer, H. Peter, Lin, Lynlee L. and Trau, Matt (2021). An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomas. Advanced Functional Materials, 32 (3) 2010296, 1-9. doi: 10.1002/adfm.202010296

An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomas

2020

Journal Article

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants

Rayner, Jenna E., Duffy, David L., Smit, Darren J., Jagirdar, Kasturee, Lee, Katie J., De’Ambrosis, Brian, Smithers, B. Mark, McMeniman, Erin K., McInerney-Leo, Aideen M., Schaider, Helmut, Stark, Mitchell S., Soyer, H. Peter and Sturm, Richard A. (2020). Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants. PLoS ONE, 15 (9) e0238529, e0238529. doi: 10.1371/journal.pone.0238529

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants

2020

Journal Article

Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls

Duffy, David L., Jagirdar, Kasturee, Lee, Katie J., McWhirter, Seamus R., McMeniman, Erin K., De’Ambrosis, Brian, Pflugfelder, Annette, Rayner, Jenna E., Whiteman, David C., Brown, Matthew A., Martin, N.G., Smithers, B.M., Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2020). Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls. Journal of Investigative Dermatology, 140 (2), 498-501.e17. doi: 10.1016/j.jid.2019.05.032

Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls

2020

Journal Article

Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer

Menon, Dinoop Ravindran, Hammerlindl, Heinz, Torrano, Joachim, Schaider, Helmut and Fujita, Mayumi (2020). Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics, 10 (14), 6261-6277. doi: 10.7150/thno.42523

Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer

2019

Journal Article

Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”

Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, Peter H. and Smithers, Mark B. (2019). Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”. Journal of Surgical Oncology, 120 (6), 1058-1059. doi: 10.1002/jso.25686

Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”

2019

Journal Article

Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer

Al Emran, Abdullah, Marzese, Diego M., Menon, Dinoop R., Hammerlindl, Heinz, Ahmed, Farzana, Richtig, Erika, Duijf, Pascal, Hoon, Dave S. B. and Schaider, Helmut (2019). Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics, 11 (7), 723-737. doi: 10.2217/epi-2018-0173

Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer

2019

Journal Article

Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization

Heitzer, Ellen, Groenewoud, Arwin, Meditz, Katharina, Lohberger, Birgit, Liegl-Atzwanger, Bernadette, Prokesch, Andreas, Kashofer, Karl, Behrens, Diana, Haybaeck, Johannes, Kolb-Lenz, Dagmar, Koefeler, Harald, Riedl, Sabrina, Schaider, Helmut, Fischer, Carina, Snaar-Jagalska, B. Ewa, de’Jong, Danielle, Szuhai, Karoly, Zweytick, Dagmar and Rinner, Beate (2019). Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Scientific Reports, 9 (1) 4096, 4096. doi: 10.1038/s41598-019-40570-1

Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization

2019

Journal Article

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming

Torrano, Joachim, Al Emran, Abdullah, Hammerlindl, Heinz and Schaider, Helmut (2019). Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. Clinical Epigenetics, 11 (1) 43, 43. doi: 10.1186/s13148-019-0644-y

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming

2019

Journal Article

Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma

Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma. Cancer Medicine, 8 (3), 1186-1196. doi: 10.1002/cam4.1978

Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma

2019

Journal Article

Cover image

Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Cover image. Cancer Medicine, 8 (3), i-i. doi: 10.1002/cam4.2129

Cover image

2019

Journal Article

A systematic review and meta-analysis of locoregional treatments for in-transit melanoma

Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2019). A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. Journal of Surgical Oncology, 119 (7) jso.25686, 887-896. doi: 10.1002/jso.25400

A systematic review and meta-analysis of locoregional treatments for in-transit melanoma

2019

Journal Article

The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review

Deen, Jacqueline and Schaider, Helmut (2019). The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review. Australasian Journal of Dermatology, 60 (3), e186-e194. doi: 10.1111/ajd.12992

The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review

2019

Conference Publication

Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma

Spoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Smith, A., Scott, E., Schaider, H., Gabrielli, B., Weninger, W. and Haass, N. (2019). Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.13859

Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma

2019

Conference Publication

ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting

Economides, A., Mar, V., Soyer, H. P., Schaider, H., Sadeghi, M. and Guitera, P. (2019). ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting. 2019 Dermcoll, Melbourne, Australia, 18 – 21 May 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.

ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting

2019

Conference Publication

Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma

Faleiro, Rebecca J., Karunarathne, Deshapriya S., Liu, Ji, Boyle, Glen, Hartel, Gunter, Hayward, Nick, Schaider, Helmut, Waddell, Nic, Schmidt, Chris and Wykes, Michelle (2019). Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Atlanta, GA, United States, 29 March - 3 April, 2019. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-4112

Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma

2018

Journal Article

Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma

Laino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter and Schaider, Helmut (2018). Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma. JAAD Case Reports, 4 (9), 921-923. doi: 10.1016/j.jdcr.2018.06.024

Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma

Funding

Current funding

  • 2024 - 2026
    Preventing the cancer-promoting effects of tacrolimus on UV-treated keratinocytes
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2024 - 2029
    Compound Discovery for Cancer Recurrence research
    Research Donation Generic
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2027
    The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2019 - 2022
    O-linked-N-acetylglucosamine transferase and ten-eleven translocation 1 facilitate therapy induced cellular reprogramming leading to acquired drug resistance in cancer
    Cancer Council Queensland
    Open grant
  • 2018 - 2022
    Improving outcomes for patients with melanoma brain metastases using novel personalised and response-adapted treatment strategies (PARF Translation Research Innovation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018
    Targeted and personalised early detection of melanoma using a 3D teledermatology network
    PA Research Foundation
    Open grant
  • 2017 - 2018
    Cutting-edge Imaging System for the Early Diagnosis of Face and Scalp Skin Cancer
    The Honda Foundation
    Open grant
  • 2017 - 2019
    Melanoma environment and heterogeneity in therapy sensitivity and resistance - Schaider
    Meehan Bequest
    Open grant
  • 2016 - 2019
    The role of chondroitin sulfate proteoglycan 4 (CSPG4) in the induction of multidruQ tolerance in melanoma cells (NO Forschung und Bildung funding led by Karl Landsteiner Uni for Med Sci)
    Karl Landsteiner University of Health Sciences
    Open grant
  • 2016
    Epigenetic remodelling driving acquired permanent drug resistance in melanoma cells
    PA Research Foundation
    Open grant
  • 2015 - 2021
    Centre of Research Excellence for the Study of Naevi
    NHMRC Centres of Research Excellence
    Open grant
  • 2015 - 2017
    Topical application of ORIL007 in two different mouse models
    Oncology Research International Ltd
    Open grant
  • 2015 - 2018
    Defining the role of Microphthalmia-associated Transcription Factor (MITF) in melanoma heterogeneity by real-time cell cycle imaging
    NHMRC Project Grant
    Open grant
  • 2015
    Next-generation cell analysis: Automated high-throughput 3D microscope and multimode microplate reader
    NHMRC Equipment Grant
    Open grant
  • 2014 - 2016
    Genetic polymorphisms associated with clinical and dermoscopic naevus signature patterns
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Targeted expression of US28/GNA12/13 fusion proteins for cancer therapy
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant

Supervision

Availability

Associate Professor Helmut Schaider is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor Helmut Schaider's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au